Yokogawa and Repligen Enhance Bioprocessing with Real-Time Analytics

Yokogawa Corporation of America and Repligen have joined forces to revolutionize the bioprocessing industry by integrating Yokogawa’s OpreX Bio Pilot with Repligen’s MAVERICK®. This collaboration introduces real-time, automated control of glucose and lactate levels in cell cultures, promising increased productivity and reduced time to market for biopharmaceuticals. 

In the competitive realm of bioprocessing, maintaining optimal cell culture conditions is vital. The partnership between Yokogawa and Repligen addresses this by enabling continuous, real-time analysis without manual sampling, simplifying complex analytical workflows. By aligning MAVERICK’s Raman-based analytics with OpreX Bio Pilot, scientists gain precise data to better manage bioreactor environments, reducing batch failures. This breakthrough not only supports effective data management and decision-making but also accelerates the research and development of biopharmaceuticals. Scheduled demonstrations and further studies in Tokyo and Waltham highlight the commitment to refining this technology.